Toripalimab

References

• FDA: US Food and Drug Administration .
• EMA: European Medicines Evaluation Agency .
• ANVISA: Brazilian Health Regulatory Agency .
• R/M NPC: Recurrent Locally Advanced or Metastatic Nasopharyngeal Cancer .
• CI: Confidence interval.
• HR: Hazard rate.

References:

• New Drug Therapy Approvals 2023 – FDA . Available at: https://www.fda.gov/media/175253/download . Accessed on: 11/25/2024.
• Junshi Biosciences Announces Positive Opinion from the European Medicines Agency's CHMP For Toripalimab . Available at: https://www.globenewswire.com/en/news-release/2024/07/26/2919683/0/en/Junshi-Biosciences-Announces-Positive-Opinion-from-the-European-Medicines-Agency-s-CHMP-For-Toripalimab.html. Accessed on: 25/11/2024.
• ANVISA approval reference – to be made available after approval.
• Zytorvi® package insert . Available at: (link pending). Accessed on: (date pending)